Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study

BACKGROUND: In randomized, controlled trials of open-angle glaucoma (OAG) or ocular hypertension (OHT), bimatoprost 0.01 % improved tolerability while retaining the intraocular pressure (IOP)-lowering efficacy of bimatoprost 0.03 %. Given geographic/racial differences in glaucoma presentation, the A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Ophthalmol
Autors principals: Chen, Ying Ying, Wang, Tsing-Hong, Liu, Catherine, Wu, Kwou-Yeung, Chiu, Shin-Lin, Simonyi, Susan, Lu, Da-Wen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5025541/
https://ncbi.nlm.nih.gov/pubmed/27633513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-016-0338-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars